Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis.

Front Pharmacol

Frontiers Media SA, Lausanne, Switzerland.

Published: May 2023

[This corrects the article DOI: 10.3389/fphar.2021.701690.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197925	PMC
http://dx.doi.org/10.3389/fphar.2023.1213053	DOI Listing

Publication Analysis

erratum comparison

comparison decitabine

decitabine azacitidine

azacitidine patients

patients acute

acute myeloid

myeloid leukemia

leukemia higher-risk

higher-risk myelodysplastic

myelodysplastic syndrome

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!